Loading insider details...
Beta
Latest Form 4 (Aug 6, 2026): Sale of 30,000 AGIO shares, $914.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 6, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Sale | 30,000 | $914.4K |
| Jul 2, 2026 | Viridian Therapeutics, Inc.\DE (VRDN) | Grant/Award | 32,341 | n/a |
| Jul 2, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 8,375 | n/a |
| Jun 23, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 3,000 | n/a |
| Apr 6, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 8,500 | n/a |
| Mar 3, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 4,000 | n/a |
| Jan 3, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 6,000 | n/a |
| Nov 13, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,454 | $61.4K |
| Nov 3, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 200 | $5.0K |
| Oct 29, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 3,302 | $82.6K |